Jorge Daniel Cárdenas Rodríguez

Jorge Daniel Cárdenas Rodríguez

Auto-generated profile, based on publicly available information

Jorge Daniel Cárdenas Rodríguez

Ministerio de Salud Publica

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2025 in Journal of the Selva Andina Research Society
Verified
Journal Article
Open access
PDF file
MLMaría Fernanda Calderón León
María Fernanda Calderón León
DMDiego Mauricio Cabrera Moyano
Diego Mauricio Cabrera Moyano
JRJorge Daniel Cárdenas Rodríguez
Jorge Daniel Cárdenas Rodríguez
ARAndrea Alexandra Saltos Román
Andrea Alexandra Saltos Román
MSMaryoli González Sánchez
Maryoli González Sánchez
The presence of a giant ovarian tumor in pregnancy is very rare, these masses are usually asymptomatic and are detected incidentally on the ultrasound examination of the first trimester or until they reach a large size, whose removal can be performed during cesarean section. We present a clinical case of a 34-year-old female patient, 36 weeks pregnant, who presented a giant ovarian tumor evidenced during the emergency cesarean section, a live newborn was obtained and a giant tumor of the left ovary was present that measured 22 x 17 cm in diameter. An elective cesarean section can be chosen along with salpingo oophorectomy in case of a giant ovarian cyst that complicates a full-term pregnancy as in the case presented. Ultrasound continues to be the most important tool in the study of adnexal masses due to its safety, availability and accuracy; however, the definitive diagnosis is granted by histopathology. The use of magnetic resonance imaging can also be used, to help distinguish benign tumors from malignant ones more accurately during pregnancy. It is important to carry out prenatal control and strict monitoring of the tumor, to decide the time of surgical treatment, in order to avoid maternal or fetal complications.

31 August 2025 in Journal of the Selva Andina Research Society
Verified
Journal Article
Open access
PDF file
MLMaría Fernanda Calderón León
María Fernanda Calderón León
DMDiego Mauricio Cabrera Moyano
Diego Mauricio Cabrera Moyano
JRJorge Daniel Cárdenas Rodríguez
Jorge Daniel Cárdenas Rodríguez
PJPaula Andrea Vásquez Jaramillo
Paula Andrea Vásquez Jaramillo
ARAndrea Alexandra Saltos Román
Andrea Alexandra Saltos Román
MSMaryoli González Sánchez
Maryoli González Sánchez
Breast cancer is the most common type in the female population, and ranks first in mortality with 10.9 % and an incidence of 38.2 % of all causes of cancer in women. The objective of this study was to determine the immunohistochemical characteristics of breast cancer and its histopathology correlation. An observational, retrospective, and correlational study was carried out that involved from 2019 to 2021 with information obtained from the pathology department of the Luis Vernaza hospital in Guayaquil, Ecuador. In this research, the results were that the most frequent breast tumor, according to pathology, was invasive ductal carcinoma in 78 %. All patients with ductal carcinoma in situ were estrogen, progesterone, and Ki67 receptors < 10 % in the vast majority (83 %). Patients with invasive lobular carcinoma had the vast majority of estrogen receptors, progesterone positive, and Ki67 > 10 %. In patients diagnosed with invasive ductal carcinoma, the overexpressed intrinsic molecular subtype HER2/neu predominated. Molecular markers obtained by immunohistochemistry are important for the classification of breast cancer subtypes, treatment selection, and prediction of prognosis. In this study, great variability and heterogeneity were noted in the different tumors, which gives them a different prognosis and therapeutic approach.